RILABNACEPT
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RILABNACEPT Trademark

Serial Number: 98348983 • Registration: 7585490

RILABNACEPT is a trademark filed by Hangzhou Gene-based Biopharmaceutical Co., Ltd. on January 9, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Hangzhou Gene-based Biopharmaceutical Co., Ltd. (2 trademarks)

Technology Bldg Xiaoshan Innovation
Dist Hangzhou 311231 , CN

Entity Type: 99

Trademark Details

Filing Date

January 9, 2024

Registration Date

December 3, 2024

Published for Opposition

September 10, 2024

Goods & Services

Anti-inflammatory and antipyretic preparations; Anti-inflammatory preparations; Chemical reagents for medical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 3, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2024 CNSA
ASSIGNED TO EXAMINER
Aug 2, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2024 NWOS
NEW APPLICATION ENTERED
Jan 9, 2024 NWAP